| Influence of the E-Cigarette Emission Profile by the Ratio of Glycerol to Propylene Glycol in E-Liquid Composition BG Ooi, D Dutta, K Kazipeta, NS Chong ACS Omega 4 (8), 13338-13348, 2019 | 66 | 2019 |
| Intestinal injury and gut permeability in sickle cell disease D Dutta, B Methe, S Amar, A Morris, SH Lim Journal of translational medicine 17 (1), 183, 2019 | 53 | 2019 |
| Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions D Dutta, SH Lim Biomarker Research 8, 31, 2020 | 49 | 2020 |
| Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events T Jang, M Poplawska, E Cimpeanu, G Mo, D Dutta, SH Lim Journal of Translational Medicine 19, 1-11, 2021 | 46 | 2021 |
| Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells R Katuru, NV Fernandes, M Elfakhani, D Dutta, N Mills, DAL Hynds, ... Experimental biology and medicine 236 (5), 604-613, 2011 | 32 | 2011 |
| l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? JN Leibovitch, AV Tambe, E Cimpeanu, M Poplawska, F Jafri, D Dutta, ... Blood Reviews 53, 100925, 2022 | 29 | 2022 |
| Fixation temperature affects DNA integrity in the testis as measured by the TUNEL assay D Dutta, I Park, NC Mills Toxicologic pathology 40 (4), 667-674, 2012 | 25 | 2012 |
| Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention D Dutta, A Aujla, BM Knoll, SH Lim British journal of haematology 188 (4), 488-493, 2020 | 22 | 2020 |
| Rifaximin for sickle cell disease SH Lim, D Dutta, J Moore American journal of hematology 94 (12), E325-E328, 2019 | 21 | 2019 |
| Rifaximin on intestinally‐related pathologic changes in sickle cell disease D Dutta, K Li, B Methe, SH Lim American Journal of Hematology 95 (4), E83-E86, 2020 | 17 | 2020 |
| Antimicrobial therapy during cancer treatment: Beyond antibacterial effects S Ghanem, CJ Kim, D Dutta, M Salifu, SH Lim Journal of Internal Medicine 290 (1), 40-56, 2021 | 16 | 2021 |
| Analysis of chemical constituents in mainstream bidi smoke OA Oladipupo, D Dutta, NS Chong BMC chemistry 13 (1), 93, 2019 | 16 | 2019 |
| Effects of rifaximin on circulating aged neutrophils in sickle cell disease D Dutta, BA Methe, A Morris, SH Lim American journal of hematology 94 (6), E175-E176, 2019 | 15 | 2019 |
| Endogenous volatile organic compounds in acute myeloid leukemia: origins and potential clinical applications D Dutta, NS Chong, SH Lim Journal of Breath Research 12 (3), 034002, 2018 | 15 | 2018 |
| L-glutamine for sickle cell disease: more than reducing redox F Jafri, G Seong, T Jang, E Cimpeanu, M Poplawska, D Dutta, SH Lim Annals of Hematology 101 (8), 1645-1654, 2022 | 14 | 2022 |
| Fecal microbiota transplant for hematologic and oncologic diseases: principle and practice M Bou Zerdan, S Niforatos, S Nasr, D Nasr, M Ombada, S John, D Dutta, ... Cancers 14 (3), 691, 2022 | 12 | 2022 |
| The lung microbiota and lung cancer: a growing relationship M Bou Zerdan, J Kassab, P Meouchy, E Haroun, R Nehme, M Bou Zerdan, ... Cancers 14 (19), 4813, 2022 | 11 | 2022 |
| Chronic graft-versus-host disease in pediatric patients: differences and challenges E Haroun, K Agrawal, J Leibovitch, J Kassab, M Zoghbi, D Dutta, SH Lim Blood Reviews 60, 101054, 2023 | 10 | 2023 |
| Intestinal pathophysiological abnormalities in steady state and after vaso‐occlusive crisis in murine sickle cell disease M Poplawska, D Dutta, M Jayaram, M Salifu, NS Chong, SH Lim British Journal of Haematology 196 (3), 777-780, 2022 | 10 | 2022 |
| Hematopoietic stem cell transplant for sickle cell disease: patient selection and timing based on sickle cell-related multiple chronic conditions T Jang, G Mo, C Stewart, L Khoury, N Ferguson, O Egini, J Muthu, D Dutta, ... Cell Transplantation 30, 09636897211046559, 2021 | 10 | 2021 |
